We are live on
!
Find out more
NRS
Neville Rodie & Shaw Portfolio holdings
AUM
$1.55B
1-Year Est. Return
46.95%
This Fund
S&P 500
This Quarter
Est. Return
+1.47%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+497.97%
AUM
$1.37B
AUM Growth
+$12.7M
(+0.93%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
271
New
23
Increased
77
Reduced
83
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$3.04M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.74M |
| 3 |
State Street
STT
|
+$1.33M |
| 4 |
Microsoft
MSFT
|
+$1.31M |
| 5 |
JPMorgan Chase
JPM
|
+$974K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$2.48M |
| 2 |
CVS Health
CVS
|
+$1.9M |
| 3 |
Apple
AAPL
|
+$1.75M |
| 4 |
ON Semiconductor
ON
|
+$1M |
| 5 |
Cleveland-Cliffs
CLF
|
+$851K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Industrials | 14.48% |
| 3 | Healthcare | 13.98% |
| 4 | Financials | 13.9% |
| 5 | Communication Services | 8.38% |
Similar funds
PMFA
NPA
IWA
BGCP
MSA
VWM
CET
ICM
Neville Rodie & Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, Neville Rodie & Shaw held 271 positions worth $1.37B, up 0.93% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Neville Rodie & Shaw's Q4 2024 filing shows 23 new, 77 increased, 83 reduced and 11 closed positions. Its largest new stake was Willis Towers Watson: 2,832 shares worth $887K. The largest sale was Qualcomm, an estimated $2.48M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.
- Neville Rodie & Shaw's largest Q4 2024 buy was Willis Towers Watson: 2,832 shares worth $887K.
- Neville Rodie & Shaw added most to Vertiv in Q4 2024, an estimated $3.04M increase.
- Neville Rodie & Shaw's biggest Q4 2024 reduction was Qualcomm, cutting an estimated $2.48M.
- Neville Rodie & Shaw fully exited CVS Health in Q4 2024, selling an estimated $1.9M.
- Neville Rodie & Shaw's ten largest holdings make up 39% of its $1.37B portfolio in Q4 2024.
- Neville Rodie & Shaw opened 23 new positions and closed 11 in Q4 2024.
- Neville Rodie & Shaw's portfolio value rose 0.93% quarter-over-quarter to $1.37B.
Based on Neville Rodie & Shaw's 13F filing for Q4 2024, filed 6 Jan 2025.